tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ocular Therapeutix $100M Spot Secondary; re-offered at $3.25

Jefferies, BofA and Piper Sandler are acting as joint book running managers for the offering.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on OCUL:

Disclaimer & DisclosureReport an Issue

1